All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Ongoing, reported early | 2006-004573-95 | Etude pharmacologique du Pemetrexed (Alimta) administré avec Cisplatine et supplémentation vitaminique chez des patients porteurs d'un mésothéliome pleural non résécable | not-yet-due | |
Reported results | 2006-004862-15 | Etude de Phase II de l'association Méta-lodobenzylguanidine I131 (MIBGI131) et Topotécan dans le traitement des neuroblastomes métastatiques réfractaires ou en rechute. | 2019-02-15 | due-trials |
Ongoing, reported early | 2007-002913-38 | Essai de phase II multicentrique sur le traitement préventif de la folliculite induite par les anti-EGFR chez des patients atteints de cancer colorectal métastatique sous Cetuximab ou atteints de canc... | not-yet-due | |
Ongoing | 2007-004651-10 | Etude de phase II multicentrique stratifiée évaluant l’efficacité et la toxicité du Sorafenib dans le traitement des angiosarcomes localement avancés ou métastatiques non accessibles à une chirurgie... | not-yet-due | |
Reported results | 2008-003620-32 | Etude Prospective Randomisée Ouverte et Multicentrique évaluant les effets sur les fonctions cognitives de l’hormonothérapie adjuvante dans le cancer du sein de la femme ménopausée | 2012-04-11 | due-trials |
Exempt | 2009-016870-33 | Cilengitide (EMD121974) in combination with irradiation in children and young adults with newly diagnosed diffuse intrinsic pontine glioma : Phase I study | not-yet-due | |
Reported results | 2010-021439-16 | Etude de phase II randomisée chez des patients porteurs d’un cancer épidermoïde métastatique de l’œsophage évaluant l’intérêt de la poursuite ou non d’un traitement cytotoxique chez des patients non p... | 2016-01-12 | due-trials |
Listed as ongoing, but also has a completion date and reported results | 2010-023135-42 | INTERNATIONAL RANDOMIZED PHASE II TRIAL OF THE COMBINATION OF VINCRISTINE AND IRINOTECAN WITH OR WITHOUT TEMOZOLOMIDE (VI OR VIT) IN CHILDREN AND ADULTS WITH REFRACTORY OR RELAPSED RHABDOMYOSARCOMA... | 2019-05-03 | bad-data |
Not reported Terminated | 2012-002214-38 | A PHASE II RANDOMIZED STUDY OF DOCETAXEL WITH OR WITHOUT NINTEDANIB (BIBF-1120) IN PATIENT RECEIVING A SECOND-LINE OF CHEMOTHERAPY FOR HER NEGATIVE, METASTATIC OR LOCALLY RECURRENT BREAST CANCER | 2016-09-15 | due-trials |
Ongoing | 2012-005743-24 | ACTIVITY AND SAFETY OF REGORAFENIB IN PATIENTS WITH METASTATIC SOFT TISSUE SARCOMA PREVIOUSLY TREATED WITH ANTHRACYCLIN-BASED CHEMOTHERAPY: A MULTINATIONAL, RANDOMIZED, PHASE II, PLACEBO-CONTROLLED TR... | not-yet-due | |
Ongoing, reported early | 2013-001146-34 | Impact of a treatment with zoledronic acid on bone mineral density in patients with metastatic castration-resistant prostate cancer, chemo-naïve and receiving abiraterone acetate Impact d’un traite... | not-yet-due | |
Other | 2015-001732-38 | EVALUATION OF SENTINEL NODE (SN) POLICY IN EARLY STAGE ENDOMETRIAL CARCINOMAS AT INTERMEDIATE AND HIGH RISK OF RECURRENCE: RANDOMIZED STUDY COMPARING SENTINEL NODE POLICY TO CURRENT FRENCH INITIAL STA... | not-yet-due | |
Other | 2016-000808-28 | Risk of infertility related to adjuvant chemotherapy in young breast cancer patients: Oocyte/embryo cryopreservation Chimiothérapie adjuvante et risque d’infertilité chez les jeunes patientes prése... | not-yet-due | |
Not reported Terminated | 2017-003660-13 | Phase II Randomized Study Measuring the Interest of Pursuing or Not the chemotherapy for Non-progressive Patients With Metastatic Esophageal Squamous-cell Cancer After 6 Weeks of LV5FU2-paclitaxel Giv... | 2022-07-05 | due-trials |
Exempt | 2018-000096-32 | Metro-PD1: a phase I/II trial evaluating anti-PD1 (Nivolumab) in combination with metronomic chemotherapy in children and teenagers with refractory /relapsing solid tumors | not-yet-due | |
Other | 2018-000410-38 | Phase III randomised trial evaluating treatment intensification with temozolomide in adults with a glioblastoma Essai de phase 3 évaluant le bénéfice d’une intensification du traitement par témozol... | not-yet-due | |
Completed, but no date | 2018-001574-22 | Efficacy of regorafenib as maintenance therapy in non-adipocytic soft tissue sarcoma having received first-line doxorubicin-based chemotherapy | bad-data | |
Other | 2018-003680-62 | Phase III randomized clinical trial evaluating hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer considering two different settings: Primary Debulking Surgery (PDS) and Interval Debu... | not-yet-due | |
Other | 2021-002540-67 | Phase 2 trial evaluating metronomic chemotherapy in patients with relapsed or refractory Wilms tumor Etude de phase II évaluant la chimiothérapie métronomique chez des patients avec une tumeur WILM... | not-yet-due |